Daily as of 3 Nov 16:00 ET
- Price
- above both $93.29 vs 50 $79.67 / 200 $60.74
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐จGolden cross 15 May 2025 ยท projected 12 bars out
Kiniksa Pharmaceuticals International, plc Class A (KNSA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.
The 50 SMA has sat above the 200 on the daily since May 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 15 May 2025 | ๐จGolden steep | daily | 12 bars out | Not tested |
| 20 Mar 2025 | ๐จGolden | 4-hour | 28 bars out | โ |
| 3 Jan 2025 | ๐Death | daily | 27 bars out | Not tested |
| 18 Nov 2024 | ๐Death | 4-hour | 28 bars out | โ |
| 16 Jul 2024 | ๐จGolden | 4-hour | 27 bars out | โ |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.